Apotex is transforming osteoporosis care across Canada with Health Canada’s green light for DENOZA™, a cutting-edge denosumab biosimilar. This thrilling launch promises to make treatment more accessible and affordable for patients everywhere!
Samsung Bioepis has just reached a thrilling milestone by securing Japan’s regulatory approval for its Stelara biosimilar, opening the door to a powerful presence in Asia’s rapidly growing biologics market, The Korea Herald reports